drugset / Trial / NCT02758067
Comparison of the Effectiveness of Brexpiprazole With That of Risperidone
RandomizedParallel-groupDouble-blindTreatment
Summary
To demonstrate that the effectiveness of brexpiprazole (2-4 mg/day) on quality of life is non-inferior to that of risperidone (4-6 mg/day) in adult patients with schizophrenia.
Timeline
- Start
- 2016-06
- Primary completion
- 2016-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brexpiprazole | Small molecule | 2 mg | Oral |
| Subject | Brexpiprazole | Small molecule | 4 mg | Oral |
| Subject | Risperidone | Other / unclassified | 4 mg | Oral |
| Subject | Risperidone | Other / unclassified | 6 mg | Oral |